Insider Trading

Slightly above 67% of Talis Biomedical's investor base is looking to short. The analysis of overall sentiment of trading Talis Biomedical Corp pink sheet suggests that many investors are alarmed at this time. Talis Biomedical's investing sentiment can be driven by a variety of factors including economic data, Talis Biomedical's earnings reports, geopolitical events, and overall market trends.
Talis Biomedical pink sheet news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Talis daily returns and investor perception about the current price of Talis Biomedical Corp as well as its diversification or hedging effects on your existing portfolios.
  
Filed transaction by Talis Biomedical Corp Director: . Insider Public Trading

Read at macroaxis.com
Talis insider trading alert for general transaction of by Young John T. Jr., Director: , on 31st of July 2024. This event was filed by Talis Biomedical Corp with SEC on 2024-07-31. Initial filing of beneficial ownership - SEC Form 3

Talis Biomedical Fundamental Analysis

We analyze Talis Biomedical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Talis Biomedical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Talis Biomedical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Total Asset

Total Asset Comparative Analysis

Talis Biomedical is currently under evaluation in total asset category among its peers. Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.

Talis Biomedical Corp Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Talis Biomedical pink sheet to make a market-neutral strategy. Peer analysis of Talis Biomedical could also be used in its relative valuation, which is a method of valuing Talis Biomedical by comparing valuation metrics with similar companies.

Peers

Talis Biomedical Related Equities

NPCENeuropace   3.99   
0%
91.0%
HSCSHeart Test   2.12   
0%
48.0%
BVSBioventus   1.09   
0%
25.0%
BBLGBone Biologics   0.89   
0%
20.0%
BJDXBluejay Diagnostics   0.65   
0%
14.0%
SSKNSTRATA Skin   0.33   
7.0%
0%
TNONTenon Medical   1.02   
23.0%
0%
NUWENuwellis   2.48   
57.0%
0%
SGHTSight Sciences   3.76   
86.0%
0%
TIVCTivic Health   4.35   
100.0%
0%
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.

Other Consideration for investing in Talis Pink Sheet

If you are still planning to invest in Talis Biomedical Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Talis Biomedical's history and understand the potential risks before investing.
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios